Heron Therapeutics Inc (HRTX)

16.47
0.03 0.18
NASDAQ
Prev Close 16.50
Open 16.34
Day Low/High 16.01 / 16.98
52 Wk Low/High 9.60 / 26.81
Volume 711.04K
Exchange NASDAQ
Shares Outstanding 90.86B
Market Cap 1.49B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Just Another Wild Day on the Small-Cap Biotech Rollercoaster

Just Another Wild Day on the Small-Cap Biotech Rollercoaster

Use long-dated calls to take some of risk out of this inherently high-beta space.

If You Like Laggards, Here Are 3 to Consider

If You Like Laggards, Here Are 3 to Consider

These companies will benefit immensely as the country experiences a burst of economic growth.

These 3 Biotechs Have Decent Values

These 3 Biotechs Have Decent Values

One would need to use covered calls to initiate positions that provide a solid amount of downside protection.

Markets, FDA, Manhattan Real Estate, New York City Exodus

Some acceleration in losses across the major indices since out last update. With options expiration today, we could see some volatility in the last hour of trading. My covered calls referenced in a previous post have not hit yet but have a good chan...

Bank Stress Tests, FDA Drug Approvals, Covid-19

Pre-market futures are now pointing to a slightly down open. Bank stress test have the financial sector under pressure as the Financial Select Sector SPDR ETF is down over 1% close to the opening bell. Zogenix should have a good day. The FDA approve...

Watch These Biotech Names on Strong Earnings

Watch These Biotech Names on Strong Earnings

Merger activity is the number 1 driver I am watching for biotech growth.

Putting My Covered Call Strategy to Work With 2 Dinged Biotech Stocks

Putting My Covered Call Strategy to Work With 2 Dinged Biotech Stocks

Sharp drops in Heron Therapeutics and Supernus Pharmaceuticals have presented opportunities to make lemonade out of lemons.

2 Small Biotech Stocks Spurt Ahead on Positive Developments

2 Small Biotech Stocks Spurt Ahead on Positive Developments

Heron Therapeutics and TG Therapeutics each gave investors reasons for cheer in the last few days.

A Good Day for Biotechs

The market has strengthened a bit since our last update. T2 Biosystems  is now up over 50% on positive developments that we chronicled in my last post. Lexicon Pharmaceuticals is up some 30% today off oversold levels. It should receive some $260 mil...

China Trade Truce, Biotech Fuel Action

Markets continue to be nicely in the black two hours into trading as resumption of U.S.-China trade talks have investors in a good mood to start off the second half of trading in 2019. Some small biotechs continue to show some strength this Monday. ...

Dealing With Biotech Stocks That Face Setbacks

Dealing With Biotech Stocks That Face Setbacks

Knowing when to continue to fish or cut bait is something that develops over time in this space.

These 3 Biotech Stocks Are Moving Closer to Profitability

These 3 Biotech Stocks Are Moving Closer to Profitability

Here are updates on small biotech/biopharma names I have profiled before.

3 Promising Small Biotech Stocks to Watch

3 Promising Small Biotech Stocks to Watch

I think there is still upside left in a variety of smaller names especially if M&A activity picks up across the industry.

Markets Struggle to Find Direction

Markets continue to meander between being slightly up or slightly down as equities struggle for a direction after yesterday's big slide. New homes sales for the month of February were above expectations with the average selling price 10% above the s...

Consider These Tier 3 Biotechs

Consider These Tier 3 Biotechs

I hope we get a decent size market decline so I can add to some stakes in what I think are already undervalued biotech holdings.

Biotech Shows Strength

The major indices have improved a tad since our last update. Biotech has shown some strength over the past two hours or so. There are two names to keep an eye on: T2 Biosystems  has been strong so far in 2018, moving from around $4 to over $5 a shar...

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

Market Wrap: Stocks Sink Across the Board

Market Wrap: Stocks Sink Across the Board

Materials and technology names led the way down on the session.

Bearish Charts of the Week: SPY, IWM

Bearish Charts of the Week: SPY, IWM

The markets have given us lots to think about here.

More Morning Musings

It appears based on the futures that the market's rally will continue today, at least at the open. Personally, I think investors are becoming complacent given what could unfold in Greece over the next week. Everyone seems to be betting that Europe w...

Where the Money Was Made the Last 5 Years

Where the Money Was Made the Last 5 Years

Only one fund category (of 20) has beaten the S&P 500 over half a decade.